# reload+after+2024-01-22 18:46:54.617315
address1§9 Cedarbrook Drive
city§Cranbury
state§NJ
zip§08512
country§United States
phone§609 659 8001
website§https://rocketpharma.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells; leukocyte adhesion deficiency-I, a genetic disorder that causes the immune system to malfunction; and pyruvate kinase deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia. The company also has a clinical stage in vivo adeno-associated virus program for Danon disease, a multi-organ lysosomal-associated disorder leading to early death due to heart failure. It has license agreements with Fred Hutchinson Cancer Research Center; Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Centro de Investigacion Biomedica En Red, and Fundacion Instituto de investigacion Sanitaria Fundacion Jimenez Diaz; UCL Business PLC; The Regents of the University of California; and REGENXBIO, Inc. The company is headquartered in Cranbury, New Jersey.
fullTimeEmployees§240
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Gaurav D. Shah M.D.', 'age': 48, 'title': 'CEO & Director', 'yearBorn': 1975, 'fiscalYear': 2022, 'totalPay': 1053223, 'exercisedValue': 0, 'unexercisedValue': 1905557}, {'maxAge': 1, 'name': 'Ms. Kinnari  Patel M.B.A., Pharm.D.', 'age': 44, 'title': 'President & COO', 'yearBorn': 1979, 'fiscalYear': 2022, 'totalPay': 849928, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. John C. Militello CPA', 'age': 50, 'title': 'VP, Senior Controller, Treasurer, Principal Accounting Officer & Interim Principal Financial Officer', 'yearBorn': 1973, 'fiscalYear': 2022, 'totalPay': 501421, 'exercisedValue': 0, 'unexercisedValue': 3457}, {'maxAge': 1, 'name': 'Mr. Mayo  Pujols', 'age': 54, 'title': 'Chief Technical Officer & Executive VP', 'yearBorn': 1969, 'fiscalYear': 2022, 'totalPay': 649711, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Raj  Prabhakar M.B.A.', 'age': 49, 'title': 'Senior VP & Chief Business Officer', 'yearBorn': 1974, 'fiscalYear': 2022, 'totalPay': 619127, 'exercisedValue': 0, 'unexercisedValue': 55650}, {'maxAge': 1, 'name': 'Mr. Martin Louis Wilson J.D.', 'age': 47, 'title': 'General Counsel, Chief Compliance Officer & Senior VP', 'yearBorn': 1976, 'fiscalYear': 2022, 'totalPay': 149950, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Kevin  Giordano', 'title': 'Director of Corporate Communications', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Isabel  Carmona J.D.', 'title': 'Senior VP & Chief Human Resources Officer', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jonathan  Schwartz M.D.', 'age': 58, 'title': 'Chief Gene Therapy Officer & Senior VP of Clinical Development', 'yearBorn': 1965, 'fiscalYear': 2022, 'totalPay': 557795, 'exercisedValue': 12521793, 'unexercisedValue': 1721615}, {'maxAge': 1, 'name': 'Dr. Gayatri R. Rao J.D., M.D.', 'title': 'Chief Development Officer of LVV & Senior VP', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
auditRisk§4
boardRisk§9
compensationRisk§7
shareHolderRightsRisk§6
overallRisk§8
governanceEpochDate§1704067200
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§1.057
currency§USD
dateShortInterest§1702598400
forwardEps§-2.32
pegRatio§0.04
exchange§NGM
quoteType§EQUITY
shortName§Rocket Pharmaceuticals, Inc.
longName§Rocket Pharmaceuticals, Inc.
firstTradeDateEpochUtc§1424269800
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§4162d708-cd89-3d56-a972-9752ce5a9280
gmtOffSetMilliseconds§-18000000
targetHighPrice§65.0
targetLowPrice§37.0
targetMeanPrice§51.75
targetMedianPrice§51.5
recommendationMean§1.7
recommendationKey§buy
numberOfAnalystOpinions§12
quickRatio§13.059
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
